Skip to main content
Log in

Is the stasis induced by orthostatism a vascular risk factor for arteries as well as for veins?

  • Original Articles
  • Published:
International Journal of Angiology

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Hyperfibrinogenemia is a vascular risk factor influenced by several conditions such as stasis induced by orthostatism. The authors suggest that stasis could also change local fibrinolytic activity. Twenty healthy subjects and 20 patients affected by primary varicose syndrome underwent blood collection from the antecubital vein and from a vein of the lower third of the leg, under baseline conditions, and after a 1 hour orthostatism. Tests for fibrinogenemia, t-PAa and PAI-1a, were carried out. After stasis induced by orthostatism, statistically significant variations of these three parameters were observed in both the control group and the varicose group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Cook NS, Ubben D (1990) Fibrinogen as a major risk factor in cardiovascular disease. TipS 11:444–451.

    PubMed  Google Scholar 

  2. Hashimoto Y (1988) Relationship between smoking and fibrinolytic system with special references to t-PA and PA inhibitor. Thromb Res 51(1):303.

    PubMed  Google Scholar 

  3. Pola P, Savi L (1978) Fibrinogenemia, determined immunonephelometrically, as a possible parameter in the evaluation of peripheral arteriosclerotic arteriopathy. Atherosclerosis 29:205–216.

    PubMed  Google Scholar 

  4. Ranby M, Bergsdorf N, Nilsson T, Melbring G, Winbald B, Bucht G (1986) Age dependance of tissue plasminogen activator concentration in plasma, as studied by an improved enzyme lined immunosorbent assay. Clin Chem 32:2160–2165.

    PubMed  Google Scholar 

  5. Takada Y, Takada A (1989) Plasma levels of t-PA free PAI-1 and a complex of t-PA with PAI-1 in human males and females at various ages. Thromb Res 55:601–609.

    PubMed  Google Scholar 

  6. Landin K, Tengborn L, Smith U (1990) Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Int Med 227:273–278.

    Google Scholar 

  7. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044–1048.

    PubMed  Google Scholar 

  8. Vague Ph, Juhan-Vague I, Ailhoud MF, Badoer Ch, Viard M, Ch A, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 35:250–263.

    PubMed  Google Scholar 

  9. Landin K, Tengborn L, Chmielewska J, von Schenck H, Smith U (1991) The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man. Thromb Haemost 65(2): 130–133.

    PubMed  Google Scholar 

  10. Sundell B, Nilsson TK, Hallmans G, Hellsten G, Dahlen GH (1989) Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein(a), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 80:9–16.

    PubMed  Google Scholar 

  11. Francis RB (1989) Clinical disorders of fibrinolysis: A critical review. Blut 59:1–14.

    PubMed  Google Scholar 

  12. Pola P, Tondi P, De Martini D, Gerardino L (1995) Influence of stasis in fibrinogen values. Int J Angiol (in press).

  13. Grimaudo V, Hauert J, Bachmann F, Kruithof EKO, (1988) Diurnal variation of the fibrinolytic system. Thromb Haemost 59:495–499.

    PubMed  Google Scholar 

  14. Nilsson K, Rosén S, Friberger P, (1987) A new kit for the determination of tissue plasminogen activator and its inhibitor in blood. Fibrinolysis 1:163–168.

    Google Scholar 

  15. Bertelé V, Mussoni L, Del Rosso G, Pintucci G, Carriero MR, Merati MG, Libretti A, De Gaetano G (1988) Defective fibrinolytic response in atherosclerotic patients—effecto of lloprost and its possible mechanism of action. Thromb Haemostas 60(2):141–144.

    Google Scholar 

  16. Keber D (1988) Mechanism of tissue plasminogen activator release during venous occlusion. Fibrinolysis (1988) 2 (suppl.2):96–103.

    Google Scholar 

  17. Keber D, Blinc A, Fettich J (1990) Increase of tissue plasminogen activator in limbs during venous occlusion: A simple haemodynamic model. Thromb Haemost 64(3):433–437.

    PubMed  Google Scholar 

  18. Speiser W, Speiser P, Minar E, Korninger C, Niessner H, Huber K, Schernthaner G, Ehringer H, Lechner K (1990) Activation of coagulation and fibrinolysis in patients with arteriosclerosis: Relation to localization of vessel disease and risk factors. Thromb Res 59:77–88.

    PubMed  Google Scholar 

  19. Thomas DP, Merton RE, Hockley J (1983) The effect of stasis on the venous endothelium: An ultrastructural study. Br J Haem 55:113–122.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Pola, P., Tondi, P., De Martini, D. et al. Is the stasis induced by orthostatism a vascular risk factor for arteries as well as for veins?. International Journal of Angiology 5, 144–148 (1996). https://doi.org/10.1007/BF02043211

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02043211

Keywords

Navigation